Mucosolvan Pre Dospelých (Ambroxol Hydrochloride)

• Mucosolvan Pre Dospelých is a mucolytic used in disorders where thick bronchial secretions impair breathing.
• Acute bronchitis: facilitates expectoration and reduces cough duration.
• Chronic bronchitis: improves mucus clearance and eases airway obstruction.
• Chronic obstructive pulmonary disease (COPD): aids in thinning secretions and supports airway patency.
• Respiratory tract infections with thick mucus: assists patients in clearing viscous sputum and alleviating discomfort.

• Ambroxol hydrochloride increases the production of pulmonary surfactant, stimulates ciliary activity, and reduces the viscosity of mucus by breaking down glycoprotein structures. These actions together enhance the clearance of bronchial secretions, making cough more productive and improving ventilation in the affected airways.

Common Side Effects

• Taste disturbance: altered taste sensation, often metallic.
• Nausea: mild to moderate feeling of queasiness.
• Vomiting: occasional episodes, usually self‑limited.
• Abdominal discomfort: mild stomach pain or cramps.
• Diarrhoea: loose stools, generally transient.
• Headache: mild to moderate intensity.

Serious or Rare Side Effects

• Allergic reactions: rash, pruritus, or angioedema.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Hepatic enzyme elevation: increased transaminases indicating liver stress.
• Eosinophilia: elevated eosinophil count, potentially signalling hypersensitivity.
• Anaphylaxis: rare but life‑threatening systemic allergic response.

Before using Mucosolvan Pre Dospelých, consider the following precautions:

• Age restrictions: use only as prescribed for appropriate age groups.
• Renal impairment: dose adjustment may be required in patients with reduced kidney function.
• Hepatic impairment: monitor liver function in patients with existing liver disease.
• Pregnancy and breastfeeding: safety not fully established; use only if clearly needed.
• Known hypersensitivity: avoid if the patient has a documented allergy to ambroxol or related compounds.
• Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Ambroxol may interact with other medicines as follows:

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase ambroxol plasma levels.
• Anticholinergic agents: can diminish the mucociliary stimulating effect of ambroxol.

Moderate Interactions (Monitor Closely)

• Antacids: may alter gastric pH and affect ambroxol absorption.
• NSAIDs: concurrent use may increase risk of gastrointestinal irritation.
• Beta‑2 agonists: additive bronchodilatory effect may require monitoring.
• Warfarin: occasional reports of altered INR; monitor coagulation parameters.
• Alcohol: may enhance central nervous system side effects such as dizziness.